STEPHENS KRISTIN (Chief Development Officer) exercised options at SYROS PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 2 exercises
Filed: 4/2/2024ACC: 0000950170-24-040320
Officer· Chief Development Officer
Since Jun 2021
-4.22K
Net shares
Net seller
$21.6K
Total sold
0
Open market trades
0B · 0S
5
Total transactions
13.67K acquired · 17.88K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+2K
Price / share
—
Trade value
—
% of position
12.7%
3/31/2024
15.79K→17.79K
Common Stock
Direct
Shares
+11.67K
Price / share
—
Trade value
—
% of position
65.6%
3/31/2024
17.79K→29.45K
Common Stock
Direct
Shares
−4.22K
Price / share
$5.12
Trade value
$21.60K
% of position
14.3%
4/1/2024
29.45K→25.24K
Total
Net shares
+9.45K
Net value
-$21.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2024 | M · Option Exercise | +2K | — | — | 12.7% | 15.79K | 17.79K |
| Common Stock Direct | 3/31/2024 | M · Option Exercise | +11.67K | — | — | 65.6% | 17.79K | 29.45K |
| Common Stock Direct | 4/1/2024 | F · Tax Withholding | −4.22K | $5.12 | $21.60K | 14.3% | 29.45K | 25.24K |
| Total | +9.45K | -$21.60K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
2K shares
Shares
−2K
Strike price
Held after
4K
Exercisable
—
3/31/2024
Restricted Stock Units
Direct
Converts to
Common Stock
11.67K shares
Shares
−11.67K
Strike price
Held after
23.33K
Exercisable
—
3/31/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock2K shares | 3/31/2024 | M · Option Exercise | −2K | — | 4K | |
| Restricted Stock Units Direct | Common Stock11.67K shares | 3/31/2024 | M · Option Exercise | −11.67K | — | 23.33K |